The hospital failed to identify the patient as at-risk for a serious blot clot condition before discharging her, state ...

With the planned purchase, Boston Scientific will gain a portfolio of devices to remove clots from blood vessels.

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...

Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190), a leading innovator in neurovascular and peripheral vascular interventional solutions, hosted its Investor Open Day at its Zhuhai Innovation ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...

The experts we spoke with agreed on one thing: tight clothing has no place on a flight. "For long-haul flights, avoid ...

In a bold move to expand its cardiovascular portfolio, Boston Scientific Corporation has announced its acquisition of Penumbra, Inc. This strategic partnership, valued at approximately $14.5 billion, ...

Australians love to travel and millions of us will catch flights or board cruise ships for overseas trips this holiday season ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.